Related references
Note: Only part of the references are listed.The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse
Dan Wang et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Experimental Gentamicin Nephrotoxicity and Agents that Modify it: A Mini-Review of Recent Research
Badreldin H. Ali et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Effective Drug Delivery System for Duchenne Muscular Dystrophy Using Hybrid Liposomes Including Gentamicin along with Reduced Toxicity
Mamiko Yukihara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Synthesis and evaluation of compounds that induce readthrough of premature termination codons
Michael E. Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
New horizons in the treatment of cystic fibrosis
A. W. Cuthbert
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Cystic Fibrosis Transmembrane Conductance Regulator Intracellular Processing, Trafficking, and Opportunities for Mutation-Specific Treatment
Mark P. Rogan et al.
CHEST (2011)
Nonsense-mediated mRNA decay (NMD) in animal embryogenesis: to die or not to die, that is the question
Jungwook Hwang et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy
Patrick Kim Chiaw et al.
ESSAYS IN BIOCHEMISTRY: ABC TRANSPORTERS (2011)
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
M. Wilschanski et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Progress in therapy for Duchenne muscular dystrophy
Rebecca J. Fairclough et al.
EXPERIMENTAL PHYSIOLOGY (2011)
New drugs for cystic fibrosis
Michael Wilschanski et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Nonsense-mediated mRNA decay caused by a frameshift mutation in a large kindred of type 2 long QT syndrome
Ignatius Gerardo Zarraga et al.
HEART RHYTHM (2011)
PTC124-Mediated Translational Readthrough of a Nonsense Mutation Causing Usher Syndrome Type 1C
T. Goldmann et al.
HUMAN GENE THERAPY (2011)
PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation
Lu Tan et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model
Cornelia Brendel et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54
Steven M. Rowe et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view
Jose M. Lopez-Novoa et al.
KIDNEY INTERNATIONAL (2011)
Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations
Manuela Vecsler et al.
PLOS ONE (2011)
Evolutionary optimization of speed and accuracy of decoding on the ribosome
Ingo Wohlgemuth et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Structural aspects of translation termination on the ribosome
Andrei A. Korostelev
RNA (2011)
Repairing faulty genes by aminoglycosides: Identification of new pharmacophore with enhanced suppression of disease-causing nonsense mutations
Jeyakumar Kandasamy et al.
MEDCHEMCOMM (2011)
Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases
Kim M. Keeling et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Isabelle Sermet-Gaudelus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Ribosome Structure and Dynamics During Translocation and Termination
Jack A. Dunkle et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 39 (2010)
NMD: RNA biology meets human genetic medicine
Madhuri Bhuvanagiri et al.
BIOCHEMICAL JOURNAL (2010)
Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
Igor Nudelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Recognition of the amber UAG stop codon by release factor RF1
Andrei Korostelev et al.
EMBO JOURNAL (2010)
Liposomes as delivery systems for antibiotics
Zuzanna Drulis-Kawa et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
Richard S. Finkel
JOURNAL OF CHILD NEUROLOGY (2010)
The Role of ABCE1 in Eukaryotic Posttermination Ribosomal Recycling
Andrey V. Pisarev et al.
MOLECULAR CELL (2010)
Structure of the 70S ribosome bound to release factor 2 and a substrate analog provides insights into catalysis of peptide release
Hong Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A comprehensive analysis of translational missense errors in the yeast Saccharomyces cerevisiae
Emily B. Kramer et al.
RNA (2010)
Beneficial Read-Through of a USH1C Nonsense Mutation by Designed Aminoglycoside NB30 in the Retina
Tobias Goldmann et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Interaction of Aminoglycosides with Human Mitochondrial 12S rRNA Carrying the Deafness-Associated Mutation
Yaping Qian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Cubilin and Megalin Co-Localize in the Neonatal Inner Ear
Jacob Tauris et al.
AUDIOLOGY AND NEURO-OTOLOGY (2009)
Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA
Virginia B. Mattis et al.
BMC NEUROSCIENCE (2009)
Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model
Virginia B. Mattis et al.
HUMAN MOLECULAR GENETICS (2009)
Poly-L-aspartic Acid Enhances and Prolongs Gentamicin-mediated Suppression of the CFTR-G542X Mutation in a Cystic Fibrosis Mouse Model
Ming Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nonaminoglycoside compounds induce readthrough of nonsense mutations
Liutao Du et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations
Igor Nudelman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Quality control by the ribosome following peptide bond formation
Hani S. Zaher et al.
NATURE (2009)
Nonsense suppression activity of PTC124 (ataluren)
Stuart W. Peltz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Reply to Peltz et al: Post-translational stabilization of the firefly luciferase reporter by PTC124 (Ataluren)
James Inglese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression
Douglas S. Auld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium
Liqun Zhang et al.
PLOS BIOLOGY (2009)
Peptide Release on the Ribosome: Mechanism and Implications for Translational Control
Elaine A. Youngman et al.
ANNUAL REVIEW OF MICROBIOLOGY (2008)
Recognition and elimination of nonsense mRNA
Oliver Muhlemann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
The clinical outcome of Hurler syndrome after stem cell transplantation
Mieke Aldenboven et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
P. Meers et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
PTC124 induces CFTR full-length production and activity in children with nonsense-mutation-mediated CF
I. Sermet-Gaudelus et al.
Journal of Cystic Fibrosis (2008)
PTC124 treatment over 3 months improves pharmacodynamic and clinical parameters in patients with nonsense-mutation-mediated CF
M. Wilschanski et al.
Journal of Cystic Fibrosis (2008)
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
Eitan Kerem et al.
LANCET (2008)
Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation termination
Hua Fan-Minogue et al.
MOLECULAR CELL (2008)
Structural basis for translation termination on the 70S ribosome
Martin Laurberg et al.
NATURE (2008)
The multiple lives of NMD factors: balancing roles in gene and genome regulation
Olaf Isken et al.
NATURE REVIEWS GENETICS (2008)
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
Ming Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Crystal structure of a translation termination complex formed with release factor RF2
Andrei Korostelev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Insights into Translational Termination from the Structure of RF2 Bound to the Ribosome
Albert Weixlbaumer et al.
SCIENCE (2008)
Aminoglycoside induced ototoxicity
O'neil W. Guthrie
TOXICOLOGY (2008)
Introducing sense into nonsense in treatments of human genetic diseases
Liat Linde et al.
TRENDS IN GENETICS (2008)
Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity
Hua Fan-Minogue et al.
RNA (2008)
In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome
Annie Rebibo-Sabbah et al.
HUMAN GENETICS (2007)
Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies
Sebastien Durand et al.
JOURNAL OF CELL BIOLOGY (2007)
Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function
Olaf Isken et al.
GENES & DEVELOPMENT (2007)
No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations
John P. Clancy et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers
Samit Hirawat et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin
Liat Linde et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations
Igor Nudelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts
Virginia B. Mattis et al.
HUMAN GENETICS (2006)
Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts
Fusako Usuki et al.
MOLECULAR THERAPY (2006)
Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model
Ming Du et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3
Elena Z. Alkalaeva et al.
CELL (2006)
Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay
I Kashima et al.
GENES & DEVELOPMENT (2006)
The role of ribosome recycling factor in dissociation of 70S ribosomes into subunits
G Hirokawa et al.
RNA (2005)
Splitting of the posttermination ribosome into subunits by the concerted action of RRF and EF-G
AV Zavialov et al.
MOLECULAR CELL (2005)
Processing of CFTR: Traversing the cellular maze - How much CFTR needs to go through to avoid cystic fibrosis?
MD Amaral
PEDIATRIC PULMONOLOGY (2005)
Sequence of steps in ribosome recycling as defined by kinetic analysis
F Peske et al.
MOLECULAR CELL (2005)
Discrimination between defects in elongation fidelity and termination efficiency insights into translational provides mechanistic readthrough
J Salas-Marco et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
The first 5 years of clinical experience with laroniclase enzyme replacement therapy for mucopolysacchariclosis I
JE Wraith
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Conservation of tandem stop codons in yeasts
H Liang et al.
GENOME BIOLOGY (2005)
Application of glycodiversification: Expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues
J Li et al.
ORGANIC LETTERS (2004)
Application of the synthetic aminosugars for glycodiversification: Synthesis and antimicrobial studies of pyranmycin
B Elchert et al.
JOURNAL OF ORGANIC CHEMISTRY (2004)
Antioxidant gene therapy can protect hearing and hair cells from ototoxicity
K Kawamoto et al.
MOLECULAR THERAPY (2004)
GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination
J Salas-Marco et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment - Third in Molecular Medicine Review Series
KJ Nowak et al.
EMBO REPORTS (2004)
A faux 3′-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay
N Amrani et al.
NATURE (2004)
Pharmacologic therapy for stop mutations: how much CFTR activity is enough?
E Kerem
CURRENT OPINION IN PULMONARY MEDICINE (2004)
Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich's disease
F Usuki et al.
ANNALS OF NEUROLOGY (2004)
Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice
M Arakawa et al.
JOURNAL OF BIOCHEMISTRY (2003)
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations
M Wilschanski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle
P Dunant et al.
MUSCLE & NERVE (2003)
Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7
T Ohnishi et al.
MOLECULAR CELL (2003)
Pyranmycins, a novel class of aminoglycosides with improved acid stability: The SAR of D-pyranoses on ring III of pyranmycin
CWT Chang et al.
ORGANIC LETTERS (2002)
α-L-iduronidase and enzyme replacement therapy for mucopoly'saccharidosis I
DA Brooks
EXPERT OPINION ON BIOLOGICAL THERAPY (2002)
Selection of tRNA by the ribosome requires a transition from an open to a closed form
JM Ogle et al.
CELL (2002)
Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene
M Du et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Poly(A)-binding protein acts in translation termination via eukaryotic release factor 3 interaction and does not influence [PSI+] propagation
B Cosson et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A posttermination ribosomal complex is the guanine nucleotide exchange factor for peptide release factor RF3
AV Zavialov et al.
CELL (2001)
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies
R Schiffelers et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis
JP Clancy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Recognition of cognate transfer RNA by the 30S ribosomal subunit
JM Ogle et al.
SCIENCE (2001)
Structure of a eukaryotic decoding region A-site RNA
SR Lynch et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of α-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation
KM Keeling et al.
HUMAN MOLECULAR GENETICS (2001)
Evidence that phosphorylation of human Upf1 protein varies with intracellular location and is mediated by a wortmannin-sensitive and rapamycin-sensitive PI 3-kinase-related kinase signaling pathway
M Pal et al.
RNA (2001)
A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity
MX Guan et al.
HUMAN MOLECULAR GENETICS (2000)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant
SH Sha et al.
HEARING RESEARCH (2000)
The accuracy of codon recognition by polypeptide release factors
DV Freistroffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations
M Wilschanski et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
